Delivery Order SPE2DB20D9636-SPE2DB24FC7XA

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The contract, valued up to $1,543.92, covers the delivery of various medications including branded and generic prescription drugs, over-the-counter products, biologics, and...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The contract has a ceiling value of $2,438.40 and an ultimate completion date of April 29, 2022. This delivery order is part of a larger indefinite delivery contract...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a wide range of pharmaceutical products and medical supplies to support the medical needs of military health facilities worldwide. The contract, valued at up to $12,508.75, covers the delivery of various medications and medical consumables, including branded and generic prescription drugs, over-the-counter...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the supply of various pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health facilities worldwide. The delivery order, valued at $7,104.00, is part of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a range of pharmaceutical products and medical supplies to support military health facilities. The contract has a ceiling value of $1,381.20 and runs through June 28, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA's...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of pharmaceutical products including prescription drugs, over-the-counter medications, and medical consumables. The contract, valued at up to $1,412.68, supports the recurring medical supply needs of military health facilities worldwide. This award is part of a larger indefinite delivery contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a wide range of pharmaceutical products and medical supplies. This order, valued at $2,319.51, is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group that has a ceiling value of up to $499,999,999. The IDC, under the DLA's SPE2DB program, allows the agency to issue delivery orders for a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The contract, valued at $1,221.12, is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which has a ceiling value of up to...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $24,948.60, is to provide a variety of pharmaceutical products and medical supplies, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The contract, valued at $1,522.35, is for the provision of a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of various Department of Defense (DoD) healthcare facilities worldwide. This delivery order is part of a larger indefinite delivery contract...
  • SPE2DB20D9636
    Indefinite Delivery Contract
  • SPE2DB20D9636-SPE2DB24FC7XA
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The $2,701.36 contract has a completion date of September 5, 2024 and is part of a larger $499,999,999 indefinite delivery contract (IDC) under the SPE2DB program that runs through December 31, 2025. This IDC allows the DLA to issue delivery orders for a comprehensive array of pharmaceutical items, from common medications to specialized drugs and medical supplies, to fulfill the diverse medical requirements of the Department of Defense (DoD) healthcare system. The contract does not have a set-aside designation.

Generated 12/4/24, 9:54 AM